GASTROESOPHAGEAL JUNCTION CARCINOMA
Clinical trials for GASTROESOPHAGEAL JUNCTION CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION CARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called TJ033721 (givastomig) in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 330 partici…
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE1 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
Could a $10 antifungal pill boost cancer cure rates?
Disease control Recruiting nowThis study tests whether adding itraconazole, a widely used antifungal medication, to standard chemotherapy and radiation can improve outcomes for people with esophageal cancer. About 78 participants with resectable tumors will receive itraconazole before surgery. The goal is to …
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New drug combo aims to fight tough stomach and esophageal cancers
Disease control Recruiting nowThis study tests whether adding the experimental drug givastomig to standard immunotherapy and chemotherapy helps people with advanced stomach or esophageal cancer live longer without their cancer growing. About 180 adults whose tumors have certain proteins (CLDN18.2 and PD-L1) w…
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE2 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
New algorithm aims to keep chemo on schedule for GI cancer patients
Symptom relief Recruiting nowThis study tests a new tool called the PAGODA algorithm to help doctors adjust chemotherapy doses proactively. The goal is to reduce unplanned treatment delays in people with gastrointestinal cancers receiving FOLFOX chemotherapy. About 420 participants will be randomly assigned …
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: NA • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated May 26, 2026 04:15 UTC
-
Cancer patients may soon skip clinic trips for home treatment
Symptom relief Recruiting nowThis study tests whether giving cancer treatment at home is preferred over going to a clinic. It involves 27 adults with various cancers in the Florida Panhandle. The goal is to see if home care improves patient satisfaction and is safe.
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 03:56 UTC